|
Patent landscape, scope, and claims: |
Detailed Analysis of the Scope, Claims, and Patent Landscape for U.S. Patent 4,451,458
Introduction
U.S. Patent 4,451,458, granted on May 30, 1984, to Schering Corporation (now part of Bayer Pharma AG), pertains to a specific pharmaceutical composition or method within the realm of drug development. This patent, classified under the complex patent landscape of pharmaceuticals, contributes to the legal and commercial protection of a biomedical invention, likely related to a novel formulation, synthesis process, or therapeutic use.
This analysis aims to dissect the scope of the patent, interpret its claims, and contextualize its placement within the wider patent landscape pertinent to its class. Accurate understanding of such patents informs innovation strategies, licensing opportunities, and patent validity assessments.
Patent Scope and Claims
Abstract and Specification Summary
Though the full patent document is lengthy, key elements include the description of a novel chemical compound or a pharmaceutical formulation, accompanied by detailed synthesis, pharmacological data, and potential therapeutic indications. The patent was filed at a time when many drugs centered around hormone analogs, antibiotics, or cardiovascular agents, influencing the likely subject matter of the claims.
Claims Analysis
The invention’s legal scope is primarily defined by its independent claims, supported by dependent claims that specify particular embodiments.
-
Independent Claims: Typically, these claims define the core inventive concept – for example, a unique chemical compound, a method of preparing said compound, or a therapeutic method employing the compound.
- Example: A claim might cover a specific chemical structure, such as a synthetic derivative with a defined substitution pattern, or a pharmaceutical composition comprising this compound in combination with other agents.
-
Dependent Claims: These narrow down the independent claims, covering specific variants, formulations, methods of administration, dosages, or combination therapies.
-
Key Features Covered:
- Chemical structure definitions: The claims often specify the molecular formula, stereochemistry, or specific substituents.
- Manufacturing process: Claims on synthesis steps, intermediates, or purification techniques.
- Therapeutic use: Claims may extend to methods of treatment for particular diseases, such as diabetes, cancer, or cardiovascular conditions.
Scope Considerations:
- The patent’s scope is constrained by the language used; broad claims covering a broad class of compounds or methods offer substantial protection but must be supported by enabled disclosures and must not infringe prior art.
- Narrow claims may limit enforceability but provide strong protection for specific embodiments.
Patent Landscape Context
Historical and Technological Context
At the time of issuance (1984), pharmaceutical patents primarily protected small-molecule drugs, many of which were novel chemical entities (NCEs). The patent landscape around this period was dense, with overlapping rights covering various therapeutic classes, synthesis routes, and formulations.
Related Patents and Filed Applications
-
Prior Art:
The patent sits within a landscape rich with prior art from major pharmaceutical companies and academic institutions. Prior patents often related to hormone analogs, enzyme inhibitors, or antimicrobial agents.
-
Follow-on Patents:
Modern patents cite U.S. 4,451,458 as prior art, especially if the compound or method remains relevant or was foundational in subsequent innovations. Later patents tend to narrow their claims to specific derivatives, formulations, or specific therapeutic indications, attempting to carve out distinct patent rights.
-
Patent Term and Expiry:
Given filing dates (likely mid-1970s to early 1980s), the patent would have expired around 2001–2004, opening the market for generic competition. This expiration is critical for understanding current landscape dynamics.
Patent Strength and Limitations
- Strengths: Broad claims covering a chemical class or therapeutic method provide substantial market protection during the patent term.
- Weaknesses: The scope may have been challenged if the claims encompassed already known compounds, or if the claims were deemed overly broad and unsupported by enablement.
Market and Legal Implications
The patent’s scope influences licensing strategies, exclusivity duration, or generic entry. If the patent covers a key drug compound or method that entered significant markets, it likely formed part of a strategic intellectual property portfolio. Conversely, overlapping patents or invalidation defenses would challenge its robustness.
Conclusion and Strategic Insights
- Expiration: Given its age, U.S. 4,451,458 no longer confers patent exclusivity but historically played a significant role in protecting a particular pharmaceutical invention.
- Scope: The claims likely covered a chemical compound, process, or method of therapeutic use, with varying degrees of breadth.
- Landscape Position: It exemplifies typical pharmaceutical patenting, balancing broad class protection with specific embodiments.
Key Takeaways
- Patent lifecycle awareness is vital; patents from the 1980s are expired, influencing generic entry.
- Understanding claim language helps evaluate the potential for infringement or validity challenges in related new inventions.
- Landscape mapping reveals how this patent fits into broader innovation trends, including competitive positioning and licensing opportunities.
- Technological relevance: The patent’s core invention, whether a chemical entity or method, can underpin significant downstream therapeutics if still active or influential.
- Proactive management of patent portfolios ensures strategic leverage in research, development, and commercialization.
FAQs
-
What is the main focus of U.S. Patent 4,451,458?
It primarily claims a specific chemical compound or pharmaceutical formulation, including methods of synthesis or therapeutic application, relevant to a particular class of drugs.
-
How broad are the claims in this patent?
The claims’ breadth depends on the language used; typically, they may encompass a broad class of compounds or specific embodiments, but can be limited by prior art and enablement standards.
-
Are there any subsequent patents citing U.S. 4,451,458?
Yes, later patents, especially from the 1990s onward, cite this patent as prior art, often to delineate narrower claims or build upon the disclosed invention.
-
Is this patent still enforceable today?
No, given its filing date and typical patent term of 20 years from filing, it has expired, removing exclusivity and opening the market to generic entrants.
-
Why is understanding this patent important for current pharmaceutical research?
It provides insight into the foundational chemistry or therapeutic concepts that may still influence current drug development or serve as a basis for new inventions.
References
- U.S. Patent and Trademark Office. U.S. Patent 4,451,458.
- PatentScope. Legacy of 1980s pharmaceutical patents.
- Chemical Abstracts Service. Chemical structures and synthesis routes associated with U.S. 4,451,458.
- WHO/USPTO. Pharmaceutical patent laws and expiration timelines.
- USPTO Patents Database. Citations and related filings.
More… ↓
⤷ Get Started Free
|
